OECOrion S.A.
Is the business good?
Margins compressing. That is the only one of 4 checks this filer's data supports, so take it as a single data point rather than a settled answer.
Operating margin has narrowed over the past few years, profitability per dollar of sales is eroding.
Where this answer is blind. The F-score rewards improvement, so an already-elite company can score mid-pack.
How good a business is OEC?
Orion S.A. earns −0.15% on the capital it employs against a 9.0% cost of capital, so growth costs more than it returns.
Return on invested capital · cost of capital 9.0% · 9.2 points below what the capital costs: growth destroys value
- Operating margin
- −0.17%
Operating margin · Specialty Chemicals median 7.4% · 12 months to Q2 2026
- Share count, year on year
- +1.7%
Share count, year on year · shareholders own a smaller slice than a year ago
- R&D as % of revenue
- 1.6%
R&D as % of revenue
| Year | Operating margin |
|---|---|
| FY2020 | 6.6% |
| FY2021 | 15% |
| FY2022 | 9.7% |
| FY2023 | 11% |
| FY2024 | 5.5% |
| FY2025 | 1.5% |
Details›
- Gross margin12 months to Q2 2026
- 18%
- Operating margin12 months to Q2 2026
- −0.17%
- Net margin12 months to Q2 2026
- −5.3%
- Free cash flow margin
- 1.4%
- R&D as % of revenue
- 1.6%
- Revenue, trailing twelve months
- $1.82B
- Free cash flow, trailing twelve months
- $26M
- Net income, trailing twelve months
- −$96M
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- −0.15%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Specialty Chemicals
Ranks #23 of 33 by RyuScore